Clinical Trial Update: Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating treatment in young patients with newly diagnosed, low-stage lymphocyte-predominant Hodgkin disease. The study includes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Nodular Lymphocyte Predominant B-cell Lymphoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Ann Arbor Stage I Childhood Hodgkin Lymphoma, Ann Arbor Stage II Childhood Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2016-08-10